687 related articles for article (PubMed ID: 14981176)
1. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
2. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.
Jack CR; Petersen RC; Xu Y; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Tangalos EG; Kokmen E
Neurology; 2000 Aug; 55(4):484-89. PubMed ID: 10953178
[TBL] [Abstract][Full Text] [Related]
3. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
[TBL] [Abstract][Full Text] [Related]
4. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
5. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
7. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
8. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
9. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
Jack CR; Petersen RC; Xu YC; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Waring SC; Tangalos EG; Kokmen E
Neurology; 1999 Apr; 52(7):1397-403. PubMed ID: 10227624
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
Chetelat G; Baron JC
Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
[TBL] [Abstract][Full Text] [Related]
11. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
12. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
[TBL] [Abstract][Full Text] [Related]
13. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
14. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
[TBL] [Abstract][Full Text] [Related]
15. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
Neuroimage; 2009 Mar; 45(1 Suppl):S3-15. PubMed ID: 19041724
[TBL] [Abstract][Full Text] [Related]
16. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
[TBL] [Abstract][Full Text] [Related]
17. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
[TBL] [Abstract][Full Text] [Related]
18. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.
Stoub TR; Rogalski EJ; Leurgans S; Bennett DA; deToledo-Morrell L
Neurobiol Aging; 2010 Jul; 31(7):1089-98. PubMed ID: 18809228
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
[TBL] [Abstract][Full Text] [Related]
20. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
